Loading data
CRDFNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 593 k USD | 683 k USD | 488 k USD | 386 k USD | 359 k USD |
| Research and development expense | — | — | — | 27.1 m USD | 17.4 m USD |
| Selling, general and administrative expense | 14.22 m USD | 12.48 m USD | 13.04 m USD | 13.18 m USD | 11.84 m USD |
| Operating profit | -48.96 m USD | -48.65 m USD | -45.41 m USD | -39.9 m USD | -28.86 m USD |
| Interest expense | — | — | — | — | 0 USD |
| Profit before tax | -45.85 m USD | -45.43 m USD | — | — | — |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -45.85 k USD | -45.43 k USD | -41.44 k USD | -38.7 k USD | -28.29 m USD |
| Net income attributable to common shareholders | -45.88 m USD | -45.46 m USD | -41.47 m USD | -38.73 m USD | -28.32 m USD |
| Basic earnings per share | -0.69 USD/share | -0.95 USD/share | -0.93 USD/share | -0.89 USD/share | -0.73 USD/share |
| Diluted earnings per share | -0.69 USD/share | -0.95 USD/share | -0.93 USD/share | -0.89 USD/share | -0.73 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.